GLP1R and type 2 diabetes mellitus: Model 2 revealed that Bacteroides dorei, Lachnoclostridium sp., Mitsuokella multacida in gut microbiota and baseline of HbA1c in patients were significant indicators for reductions in HbA1c in T2D patients treated with GLP-1 RA.